source
- Mirum readies FDA filing after positive Phase 3 results for hepatitis D therapyMirum Pharmaceuticals announced that its hepatitis D candidate has met its primary goals in the second of two pivotal studies. The company said the data support moving the product toward regulatory…
- Global scale, regional proximity and unified quality systems boost biologics supply resilienceThe piece explains that creating resilient biomanufacturing supply networks starts with leveraging a global scale of production to spread risk and capacity. It adds that locating facilities closer…